Page last updated: 2024-09-04

tipifarnib and prednisone

tipifarnib has been researched along with prednisone in 1 studies

Compound Research Comparison

Studies
(tipifarnib)
Trials
(tipifarnib)
Recent Studies (post-2010)
(tipifarnib)
Studies
(prednisone)
Trials
(prednisone)
Recent Studies (post-2010) (prednisone)
309929441,2225,2748,409

Protein Interaction Comparison

ProteinTaxonomytipifarnib (IC50)prednisone (IC50)
Glucocorticoid receptorHomo sapiens (human)1.146
Glycine receptor subunit alpha-1Rattus norvegicus (Norway rat)1.146
Glycine receptor subunit betaRattus norvegicus (Norway rat)1.146
Glycine receptor subunit alpha-2Rattus norvegicus (Norway rat)1.146
Glycine receptor subunit alpha-3Rattus norvegicus (Norway rat)1.146

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies

Other Studies

1 other study(ies) available for tipifarnib and prednisone

ArticleYear
48th annual meeting of the American Society of Hematology December 9-12, 2006, Orlando, FL.
    Clinical lymphoma & myeloma, 2007, Volume: 7, Issue:4

    Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Disease Progression; Drug Therapy, Combination; Hematologic Diseases; Hematology; Humans; Lenalidomide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Melphalan; Multiple Myeloma; Prednisone; Pyrazines; Quinolones; Recurrence; Stem Cell Transplantation; Thalidomide; Transplantation Conditioning; Transplantation, Autologous

2007